These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9764797)

  • 41. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors.
    Olivé A; Salavert A; Manríquez M; Clotet B; Moragas A
    Ann Rheum Dis; 1998 Dec; 57(12):749. PubMed ID: 10070278
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatotoxicity associated with ritonavir.
    Picard O; Rosmorduc O; Cabane J
    Ann Intern Med; 1998 Oct; 129(8):670-1. PubMed ID: 9786823
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypermenorrhea associated with ritonavir.
    Nielsen H
    Lancet; 1999 Mar; 353(9155):811-2. PubMed ID: 10459969
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal stone composed of ritonavir.
    Zhao AM; Angoff NR
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31266762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ritonavir-associated myasthenia gravis.
    Saadat K; Kaminski HJ
    Muscle Nerve; 1998 May; 21(5):680-1. PubMed ID: 9572258
    [No Abstract]   [Full Text] [Related]  

  • 46. [Median nail dystrophy and ritonavir].
    Schmutz JL; Tréchot P
    Ann Dermatol Venereol; 2014; 141(6-7):485-6. PubMed ID: 24951155
    [No Abstract]   [Full Text] [Related]  

  • 47. Re: Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir.
    Leiner S
    Retina; 2012 Feb; 32(2):411; author reply 412. PubMed ID: 22277908
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients.
    Pesko B; Deng A; Chan JD; Neme S; Dhanireddy S; Jain R
    Clin Infect Dis; 2022 Nov; 75(11):2049-2050. PubMed ID: 35869852
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV link to bad drug reactions.
    Nurs Times; 1990 Nov 28-Dec 4; 86(48):10. PubMed ID: 2255591
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware.
    Ratain MJ; Greenblatt DJ
    J Clin Pharmacol; 2022 Aug; 62(8):925-927. PubMed ID: 35412678
    [No Abstract]   [Full Text] [Related]  

  • 51. Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women.
    Weinberg A; Allshouse A; Kinzie K; Cho A; Davies JK; Mc Farland EJ
    J AIDS Clin Res; 2015 Jun; 6(6):. PubMed ID: 26236558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV, Hepatitis B, and Hepatitis C in Zambia.
    Kapembwa KC; Goldman JD; Lakhi S; Banda Y; Bowa K; Vermund SH; Mulenga J; Chama D; Chi BH
    J Glob Infect Dis; 2011 Jul; 3(3):269-74. PubMed ID: 21887060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation in HCV/HIV positive patients.
    Sugawara Y; Tamura S; Kokudo N
    World J Gastrointest Surg; 2011 Feb; 3(2):21-8. PubMed ID: 21394322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospitalization due to adverse drug reactions and drug interactions before and after HAART.
    Foisy MM; Gough K; Quan CM; Harris K; Ibanez D; Phillips A
    Can J Infect Dis; 2000 Jul; 11(4):193-201. PubMed ID: 18159290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
    Ofotokun I; Smithson SE; Lu C; Easley KA; Lennox JL
    Am J Med Sci; 2007 Nov; 334(5):334-41. PubMed ID: 18004087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.
    Guitton E; Montastruc JL; Lapeyre-Mestre M;
    Eur J Clin Pharmacol; 2006 Mar; 62(3):243-9. PubMed ID: 16416303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
    Núñez M; Soriano V
    Drug Saf; 2005; 28(1):53-66. PubMed ID: 15649105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C and HIV-1 coinfection.
    Mohsen AH; Easterbrook P; Taylor CB; Norris S
    Gut; 2002 Oct; 51(4):601-8. PubMed ID: 12235089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.
    Nelson KE; Thomas DL
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):867-70. PubMed ID: 11527794
    [No Abstract]   [Full Text] [Related]  

  • 60. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.
    Janoff EN; Smith PD
    Gastroenterology; 2001 Feb; 120(3):607-21. PubMed ID: 11179239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.